Altris AI: Revolutionizing OCT Analysis in Eye Care

Altris AI is a cutting-edge, FDA-cleared and CE-certified AI Decision Support platform designed by retina experts for ophthalmologists, optometrists, and eye care professionals worldwide. Built to enhance diagnostic accuracy and treatment monitoring, it analyzes Optical Coherence Tomography (OCT) scans with advanced machine learning, detecting over 70 retinal biomarkers and pathologies—including early glaucoma risk through GCC asymmetry and Optic Disc Analysis, diabetic retinopathy via ETDRS grid visualization, and dry/wet AMD with drusen counting and progression tracking. The system is vendor-neutral, compatible with any OCT device, and integrates seamlessly with EHR/EMR systems. With end-to-end encryption, HIPAA and GDPR compliance, and options for cloud or on-premises data storage, Altris AI ensures secure, privacy-first operation. It empowers clinicians with quantitative, objective insights, automated triage, and intuitive color-coded visuals to improve patient communication and clinical confidence. Trusted by over 500 eye care businesses and a global community of 18,000 eye care professionals, Altris AI is also a valuable asset in clinical research and pharmaceutical drug trials, enabling standardized, high-accuracy image interpretation at scale.

Key Features:

• AI-powered Optic Disc Analysis for glaucoma risk assessment
• Ganglion Cell Complex (GCC) Asymmetry analysis for early glaucoma detection
• Detection of over 70 retinal pathologies and biomarkers
• Early glaucoma risk assessment with high sensitivity and specificity
• Automated patient triage with AI severity detection
• Quantitative progression tracking for disease monitoring
• 12-layer retina segmentation and manual biomarker measurements
• Automated drusen count and EDTRS maps for detailed analysis
• Intuitive visualizations including percentage changes, maps, and graphs for longitudinal data
• Nanometer-level precision in measuring biomarker changes
• Support for DICOM, JPG, and PNG formats
• Custom report generation for patient education and practice branding
• Vendor-neutral compatibility with all OCT devices
• Integration with any EHR or EMR system
• Onboarding training and customization support
• End-to-end encryption and data tokenization for privacy
• Compliance with FDA 510(k), CE, HIPAA, and GDPR standards
• Cloud or on-premises data storage options
• 14-day free trial with full platform access
• Altris Education OCT: free mobile app for OCT interpretation training used by over 17,000 professionals

Pricing: Altris AI offers a 14-day free trial with full access, followed by a subscription-based model tailored to clinical and research needs.

Conclusion: Altris AI stands as a transformative force in ophthalmic diagnostics, combining clinical expertise, regulatory compliance, and powerful AI to deliver accurate, efficient, and patient-centered insights—making it an essential tool for modern eye care professionals aiming to elevate diagnostic standards and improve long-term outcomes.